Evidence map›Paper›PMID 32500939›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2020

Controversies regarding shielding and susceptibility to COVID-19 disease in liver transplant recipients in the United Kingdom.

Angus John Hann, Hanns Lembach, Siobhan C McKay, Moira Perrin, John Isaac, Ye H Oo, David Mutimer, Darius F Mirza, Hermien Hartog, Thamara Perera

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. COVID-19, liver transplant, and immunosuppression: Allies or foes?Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  4. Controversies regarding shielding and susceptibility to COVID-19 disease in liver transplant recipients in the United Kingdom.Transplant infectious disease : an official journal of the Transplantation Society · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Angus John HannThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.ORCID 0000-0003-4431-3642
Hanns LembachThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Siobhan C McKayThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Moira PerrinThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
John IsaacThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Ye H OoThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
David MutimerThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Darius F MirzaThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Hermien HartogThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
Thamara PereraThe Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.ORCID 0000-0002-5417-3850
Queen Elizabeth Hospital Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Cross InfectionLiver TransplantationMiddle East Respiratory Syndrome CoronavirusHumansRisk FactorsSARS-CoV-2Transplant RecipientsUnited Kingdom

Identifiers

PMID32500939
PMCPMC7300473
OpenAlexW3033553734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.